Knight Therapeutics
(TSX) GUD
Knight Therapeutics Financials at a Glance
Market Cap
CA$906.20M
Revenue (TTM)
CA$510.45M
Net Income (TTM)
CA$5.61M
EPS (TTM)
CA$0.06
P/E Ratio
158.32
Dividend
CA$0.00
Beta (Volatility)
0.43 (Low)
Dividend
CA$0.00
Beta (Volatility)
0.43 (Low)
Price
CA$9.34
Volume
16,773
Open
CA$9.22
Price
CA$9.34
Volume
16,773
Open
CA$9.22
Previous Close
CA$9.23
Daily Range
CA$9.22 - CA$9.36
52-Week Range
CA$5.66 - CA$9.59
Estimated Earnings Date
Aug 6, 2026
Dividend
CA$0.00
Beta (Volatility)
0.43 (Low)
Price
CA$9.34
Volume
16,773
Open
CA$9.22
Previous Close
CA$9.23
Daily Range
CA$9.22 - CA$9.36
52-Week Range
CA$5.66 - CA$9.59
Estimated Earnings Date
Aug 6, 2026
GUD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Knight Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
830
CEO
Samira Sakhia, MBA
Website
www.gud-knight.comHeadquarters
Montreal, QC H3Z 3B8, CA
GUD Financials
Key Financial Metrics (TTM)
Gross Margin
37.32%
Operating Margin
2.70%
Net Income Margin
1.10%
Return on Equity
0.73%
Return on Capital
-0.26%
Return on Assets
0.52%
Earnings Yield
0.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$906.20M
Shares Outstanding
98.18M
Volume
16.77K
Avg. Volume
83.63K
Financials (TTM)
Gross Profit
CA$190.52M
Operating Income
CA$13.77M
EBITDA
CA$65.18M
Operating Cash Flow
CA$105.56M
Capital Expenditure
-CA$29.37M
Free Cash Flow
CA$76.19M
Cash & ST Invst.
CA$127.29M
Total Debt
CA$69.78M
Knight Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$148.44M
+68.5%
Gross Profit
CA$54.44M
+56.1%
Gross Margin
36.67%
N/A
Market Cap
CA$906.20M
N/A
Market Cap/Employee
CA$1.22M
N/A
Employees
745
N/A
Net Income
CA$13.17M
+502.7%
EBITDA
CA$26.77M
+106.9%
Quarterly Fundamentals
Total Cash
CA$127.29M
-29.6%
Total Debt
CA$69.78M
+29.4%
Accounts Receivable
CA$156.61M
+24.8%
Inventory
CA$141.92M
+1.3%
Long Term Debt
CA$48.17M
+62.1%
Short Term Debt
CA$21.61M
-10.8%
Return on Assets
0.52%
N/A
Return on Invested Capital
1.54%
N/A
Free Cash Flow
CA$37.12M
+119845.2%
Operating Cash Flow
CA$40.45M
+1002.1%